| Literature DB >> 21876966 |
Augusto César Ferreira de Moraes1, Thayla Regina Mortean Delaporte, Carlos Alexandre Molena-Fernandes, Mário Cícero Falcão.
Abstract
OBJECTIVE: To estimate the prevalence of medicine use among high school students (14-18 years old) living in an urban area in Southern Brazil and the proportion who self-medicate and to explore the association between medicine use and demographic, socioeconomic, and behavioral variables.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21876966 PMCID: PMC3148456 DOI: 10.1590/s1807-59322011000700005
Source DB: PubMed Journal: Clinics (Sao Paulo) ISSN: 1807-5932 Impact factor: 2.365
The unadjusted prevalence (%) of medicine use and the adjusted prevalence ratio (PR) and 95% confidence interval (CI95%) according to the independent variables. Maringá – Brazil (2007).
| Levela | Variables | n | Medicine use | |||||
| % | Unadjusted analysis | Adjusted analysis | ||||||
| PR (CI95%) | PR (CI95%) | |||||||
| 1 | <0.001 | <0.001 | <0.001 | |||||
| Male | 451 | 45.7 | 0.71 (0.63-0.80) | 0.69 (0.61-0.78) | ||||
| Female | 540 | 64.3 | 1.00 | 1.00 | ||||
| 0.069 | 0.054 | 0.011 | ||||||
| 14 | 86 | 50.0 | 1.00 | 1.00 | ||||
| 15 | 286 | 52.5 | 1.04 (0.82-1.33) | 1.05 (0.82-1.33) | ||||
| 16 | 368 | 57.6 | 1.15 (0.91-1.44) | 1.12 (0.89-1.42) | ||||
| 17+18 | 251 | 59.0 | 1.17 (0.93-1.49) | 1.24 (1.01-1.57) | ||||
| 0. 487 | 0. 502 | 0.403 | ||||||
| Yes | 899 | 56.1 | 1.00 | 1.00 | ||||
| No | 92 | 53.3 | 0.95 (0.77-1.16) | 0.92 (0.75-1.11) | ||||
| 2 | 0. 116 | 0.082 | 0.136 | |||||
| A (richest) | 140 | 64.3 | 1.24 (0.94-1.63) | 1.30 (0.98-1.71) | ||||
| B | 521 | 55.7 | 1.07 (0.83-1.39) | 1.12 (0.86-1.45) | ||||
| C | 270 | 52.8 | 1.01 (0.77-1.33) | 1.03 (0.78-1.35) | ||||
| D+E (poorest) | 60 | 51.7 | 1.00 | 1.00 | ||||
| 0.035 | 0.047 | 0.004 | ||||||
| No | 797 | 54.3 | 1.00 | 1.00 | ||||
| Yes | 194 | 61.9 | 1.13 (1.01-1.29) | 1.21 (1.06-1.38) | ||||
| 3 | 0.045 | 0.019 | 0. 036 | |||||
| No | 934 | 55.0 | 1.00 | 1.00 | ||||
| Yes | 57 | 68.4 | 1.24 (1.03-1.49) | 1.20 (1.01-1.43) | ||||
| 0. 526 | 0.523 | 0.97 | ||||||
| No | 711 | 57.1 | 1.00 | 1.00 | ||||
| Yes | 280 | 55.2 | 1.03 (0.91-1.16) | 1.00 (0.89-1.12) | ||||
| 991 | 55.6 | |||||||
- other options included grandparents, alone, hostel, husband and/or wife.
- Wald test for heterogeneity.
- Wald test for trend.
a – The effect of each variable on the outcome is adjusted for other variables in the same level or above in the hierarchical model.
b – Variables with p>0.2 were excluded from the model.
The prevalence (%) of reasons for (chronic and occasional) medicine use within the prior 15 days among adolescents in Maringá – Brazil (2007), according to the independent variables.
| Variables | n | % Reason for use | ||
| eventual | chronic | |||
| 0.020 | ||||
| Male | 205 | 80.0 | 20.0 | |
| Female | 346 | 70.8 | 29.2 | |
| 0.173 | ||||
| 14 | 43 | 81.4 | 18.6 | |
| 15 | 149 | 79.2 | 20.8 | |
| 16 | 211 | 72.5 | 27.5 | |
| 17+18 | 148 | 69.6 | 30.4 | |
| 0.389 | ||||
| Yes | 503 | 74.7 | 25.3 | |
| No | 48 | 68.7 | 31.3 | |
| 0.152 | ||||
| A (richest) | 90 | 64.4 | 35.6 | |
| B | 289 | 76.5 | 23.5 | |
| C | 141 | 75.2 | 24.8 | |
| D+E (poorest) | 31 | 77.4 | 22.6 | |
| 0.346 | ||||
| No | 431 | 75.2 | 24.8 | |
| Yes | 120 | 70.8 | 29.2 | |
| 0.019 | ||||
| No | 512 | 73.8 | 26.2 | |
| Yes | 39 | 64.1 | 35.9 | |
| 0. 449 | ||||
| No | 369 | 74.5 | 25.5 | |
| Yes | 182 | 73.6 | 26.4 | |
| 551 | 74.2 | 25.8 | ||
- others options included grandparents, alone, hostel, husband and/or wife.
- Wald test for heterogeneity.
- Wald test for trend.
The prevalence of not knowing the medication's name among adolescents using medications within the prior 15 days in Maringá – Brazil (2007), according to the independent variables.
| Variables | n | no knowledge of the name | |
| % | |||
| <0.001 | |||
| Male | 205 | 67.8 | |
| Female | 346 | 85.0 | |
| 0.034 | |||
| 14 | 43 | 69.8 | |
| 15 | 149 | 79.2 | |
| 16 | 211 | 74.8 | |
| 17+18 | 148 | 85.8 | |
| 0.141 | |||
| Yes | 503 | 77.7 | |
| No | 48 | 87.5 | |
| 0.129 | |||
| A (richest) | 90 | 86.7 | |
| B | 289 | 78.2 | |
| C | 141 | 73.8 | |
| D+E (poorest) | 31 | 80.7 | |
| 0.532 | |||
| No | 431 | 78.0 | |
| Yes | 120 | 80.8 | |
| 0.027 | |||
| No | 512 | 77.5 | |
| Yes | 39 | 92.3 | |
| 0.112 | |||
| No | 369 | 80.2 | |
| Yes | 182 | 75.3 | |
| 0.003 | |||
| Eventual | 409 | 75.6 | |
| Chronic | 142 | 87.3 | |
| 551 | 78.6 | ||
- other options included grandparents, alone, hostel, husband and/or wife.
- Wald test for heterogeneity.
- Wald test for trend.
The association with the independent variables and the prevalence (%) of medicine use among adolescents who used medicine within the prior 15 days in Maringá – Brazil (2007), according to the characteristics of the prescription.
| Variables | n | Prescription | |||
| Current | old | self medication | |||
| 0.23 | |||||
| Male | 206 | 33.5 | 9.7 | 56.8 | |
| Female | 347 | 42.1 | 6.7 | 51.1 | |
| 0.45 | |||||
| 14 | 43 | 48.8 | 9.3 | 41.9 | |
| 15 | 150 | 36.0 | 10.0 | 54.0 | |
| 16 | 212 | 35.9 | 7.6 | 56.7 | |
| 17 e 18 | 148 | 43.2 | 6.1 | 50.7 | |
| 0.001 | |||||
| Parents | 504 | 38.1 | 7.9 | 54.0 | |
| Others | 49 | 46.9 | 8.2 | 44.9 | |
| 0.32 | |||||
| A (richest) | 31 | 47.8 | 6.7 | 45.5 | |
| B | 90 | 36.6 | 7.9 | 55.5 | |
| C | 290 | 40.1 | 7.8 | 52.2 | |
| D+E (poorest) | 142 | 29.0 | 12.9 | 58.1 | |
| <0.001 | |||||
| No | 120 | 25.8 | 11.7 | 62.5 | |
| Yes | 433 | 42.6 | 6.9 | 50.5 | |
| 0.0 | 0.21 | ||||
| No | 514 | 39.3 | 8.4 | 52.4 | |
| Yes | 39 | 33.3 | 2.6 | 64.2 | |
| 0.11 | |||||
| No | 371 | 38.5 | 10.2 | 51.2 | |
| Yes | 182 | 39.6 | 3.3 | 57.0 | |
| 553 | 38.9 | 8 | 52.6 | ||
- other options included grandparents, alone, hostel, husband and/or wife.
- Fisher Chi-square test with Yates' correction.
- Mantel-Haenszel Chi-square test.
The prevalence (%) of medicine use, the unadjusted and the adjusted prevalence ratios (PR) and the 95% confidence intervals (CI95%) for adolescents who used medicine within the prior 15 days in Maringá – Brazil (2007), according to the independent variables.
| Level | Variables | n | Self medication | |||||
| % | Unadjusted analysis | Adjusted analysis | ||||||
| PR (CI95%) | p-value | PR (CI95%) | ||||||
| 1 | 0.026 | 0.022 | 0.02 | |||||
| Male | 205 | 57.2 | 1.16 (1.02-1.30) | 1.16 (1.01-1.32) | ||||
| Female | 346 | 66.8 | 1.00 | 1.00 | ||||
| 0.158 | 0.195 | 0.737 | ||||||
| 14 | 43 | 51.2 | 1.00 | 1.00 | ||||
| 15 | 149 | 63.8 | 1.29 (0.88-1.89) | 1.31 (0.89-1.93) | ||||
| 16 | 211 | 64.5 | 1.35 (0.93-1.96) | 1.39 (0.96-2.02) | ||||
| 17+18 | 148 | 55.4 | 1.21 (0.82-1.78) | 1.23 (0.83-1.81) | ||||
| 0.196 | 0.239 | 0.280 | ||||||
| Yes | 503 | 61.6 | 1.00 | 1.00 | ||||
| No | 48 | 52.1 | 0.83 (0.60-1.14) | 0.82 (0.60-1.13) | ||||
| 2 | 0.168 | 0.172 | 0.994 | |||||
| A (richest) | 90 | 52.2 | 0.74 (0.53-1.14) | 0.80 (0.54-1.17) | ||||
| B | 289 | 63.3 | 0.95 (0.69-1.31) | 0.98 (0.71-1.36) | ||||
| C | 141 | 58.9 | 0.89 (0.63-1.25) | 0.92 (0.65-1.30) | ||||
| D+E (poorest) | 31 | 71.0 | 1.00 | 1.00 | ||||
| 0.001 | <0.001 | <0.001 | ||||||
| No | 431 | 57.1 | 1.00 | 1.00 | ||||
| Yes | 120 | 74.2 | 1.23 (1.04-1.46) | 1.21 (1.01-1.44) | ||||
| 3 | 0.436 | 0.402 | 0.577 | |||||
| No | 512 | 60.4 | 1.00 | 1.00 | ||||
| Yes | 39 | 66.7 | 1.22 (0.95-1.57) | 1.17 (0.91-1.51) | ||||
| 0.904 | 0. 904 | 0.908 | ||||||
| No | 369 | 61.0 | 1.00 | 1.00 | ||||
| Yes | 182 | 60.4 | 1.11 (0.95-1.30) | 1.10 (0.93-1.29) | ||||
| 4 | <0.001 | <0.001 | <0.001 | |||||
| Eventual | 409 | 67.5 | 1.00 | 1.00 | ||||
| Chronic | 142 | 41.6 | 0.33 (0.22-0.50) | 0.34 (0.22-0.58) | ||||
| 551 | 60.8 | |||||||
- other options included grandparents, alone, hostel, husband and/or wife.
- Wald test for heterogeneity.
- Wald test for trend.
a – The effect of each variable on the outcome is adjusted for other variables in the same level or above in the hierarchical model.
b – Variables with p>0.2 were excluded from the model.
Figure 1A: The prevalence of the reason for medication use (occasional or chronic) and seeking a physician's advice (current prescription, old prescription and self-medication); B: The prevalence of whose recommendations prevail when adolescents self-medicate (Maringá/PR – Brazil, 2007).